NATCO Pharma Buyback 2023 description – Natco Pharma is a vertically integrated and R&D-focused pharmaceutical company engaged in developing, manufacturing, and marketing finished dosage formulations (FDF) and active pharmaceutical ingredients (APIs). The company’s focus is primarily on niche therapeutic areas and complex products.
It markets and distributes its products in over 40 countries across geographies including the United States, India, Europe, and the rest of the world (RoW). Natco Pharma manufactures API products which are primarily used for captive consumption in its FDF products and are also sold to customers in various international markets such as Brazil, Europe, and the USA.
Natco Pharma is also engaged in the contract manufacturing business, whereby it undertakes selected contracts with pharmaceutical companies to manufacture and supply pharmaceutical products. The company has recently diversified into the business of crop health sciences to leverage its skills in organic chemistry.
NATCO Pharma Buyback 2023 Details
| NATCO Pharma Buyback Dates | 21 Mar – 12 May 2023 |
| NATCO Pharma Buyback Maximum Price | INR 700 per share |
| Market Price on Buyback Approval | INR 568 per share |
| Buyback Premium on Market Price | 23.24% |
| Buyback Offer Size (Minimum Shares) | 30,00,000 shares |
| Buyback Offer Size (Maximum Amount) | INR 210 crore |
| Offer Type | Open Market (Stock Exchange) |
| Promoter Participation | No |
| Face Value | INR 2 per share |
| Listing At | BSE, NSE |
Buyback Closure Details
| Buyback Average Price | INR 609.17 per share |
| Buyback Offer Size (Shares) | 34,47,295 shares |
| Buyback Offer Size (Amount) | INR 210 crore |
NATCO Pharma Buyback Dates (Timeline)
| Board Meeting Intimation for Buyback Proposal | 2 March 2023 |
| Buyback Approval Date | 8 March 2023 |
| Public Announcement of Buyback | 10 March 2023 |
| NATCO Pharma Buyback Record Date | Not Applicable |
| Buyback Opening Date | 21 March 2023 |
| Buyback Closing Date | 12 May 2023 |
NATCO Pharma Buyback 2023 Documents
Completion of Buyback
Public Announcement
Board Approval
Upcoming Share Buyback
NATCO Pharma Buyback Entitlement Ratio
There is no shareholder entitlement since the buyback will be conducted through open market purchases.
NATCO Pharma Financial Performance
| FY 2020 | FY 2021 | FY 2022 | |
| Total Income | 1,915.0 | 2,052.1 | 1,944.8 |
| Total Expenses | 1,453.7 | 1,576.1 | 1,841.6 |
| Net income | 458.1 | 442.4 | 170.0 |
Registrar of NATCO Pharma Buyback 2023
VENTURE CAPITAL AND CORPORATE INVESTMENTS PRIVATE LIMITED
12-10-167, Bharatnagar,
Hyderabad -500018, Andhra Pradesh, India
Phone:Â 040 23818475
Email:Â [email protected]
Website: www.vccipl.com
Manager of NATCO Pharma Buyback 2023
DAM CAPITAL ADVISORS LIMITED
One BKC, Tower C,
15th Floor, Unit No.1511,
Bandra Kurla Complex,
Bandra (East), Mumbai 400051
Phone:Â +912242022500
Email:Â [email protected]
Website: www.damcapital.in
Process to Participate in NATCO Pharma Limited Buyback
Buybacks are conducted either through a tender process or an open market (stock exchanges).
Through Tender Process
All eligible shareholders of the company who own shares in the physical or demat form on the record date may participate in the buyback offer through their stockbroker. The eligible shareholders who hold the shares in demat form must notify their brokers of the details of the equity shares that they wish to tender in the buyback offer.
The shareholder must transfer the tendered shares to the clearing corporation’s Special account. In turn, the broker would place a buyback order on the stock exchange.
The eligible shareholders who own the shares in physical form must present their broker with the original share certificates and supporting documents. After document verification is complete, the broker places an order on the stock exchange and submits the original share certificate and TRS (Transaction Registration Slip) to the registrar.
Through Open Market (Stock Exchanges)
Investor shareholders don’t have to do anything as the company purchases shares through the open market at the prevailing rates and cancels the shares. Since the shares in circulation are reduced by these operations, the fair value of the remaining shares increases, effectively making them more valuable.
Frequently Asked Questions
What are NATCO Pharma Buyback dates?
NATCO Pharma shares Buyback opens on 21 March 2023 and closes on 12 May 2023.
Which type of buyback is NATCO Pharma Buyback offer?
NATCO Pharma Buyback is an open market offer.
What is NATCO Pharma Buyback price?
NATCO Pharma Buyback price is INR 700 per share.
What is NATCO’s Buyback record date?
NATCO Pharma Buyback record date is Not Applicable.
How to participate in NATCO Share Buyback?
NATCO Pharma share buyback will be conducted through open market purchases and thus, no special participation is required from investors.
